HIV PrEP update & HIV prescriber update in Adelaide

ASHM, October 2018

HIV PrEP Update for GPs and Practice Nurses

This training will provide GPs, Nurses, and Health Professionals working in primary care an update on strategies available for the prevention of HIV transmission, focusing on prevention particularly pre-exposure prophylaxis (PrEP).

– Date Tuesday, 23 October 2018
– Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA 5000
– Time 6:15pm – 9:30 pm (Registration from 6:15pm, webinar broadcasts from 6:45pm)

At the end of this update, participants will be able to;
– Describe HIV epidemiology in Australia and the different HIV prevention
strategies
– Explain the role of HIV treatment and management
–  Provide patient education on the effectiveness and appropriate use of
PrEP/PEP
– Identify the prescribing pathways of PrEP within your local jurisdiction

This evening educational session will be presented by Dr Charlotte Bell, Sexual
Health Physician – Royal Adelaide Hospital.

This course is also available as a webinar, please contact Emma Williams here
for webinar registration

Register for this course at:
http://www.ashm.org.au/training/
Registrations close: Friday, 19 October 2018

Download flyer here: HIV PrEP Update_23Oct2018


HIV s100 Prescriber Dinner Update: 2018 IAS Conference Report Back and
Complex HIV Case Discussion

ASHM would like to invite HIV s100 Prescribers and medical practitioners in South Australia to attend this dinner training.

– Date Wednesday, 24 October 2018
– Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA 5000
– Time 6:15pm – 9:30 pm (Registration starts 6:15pm, Webinar from 6:50pm)
– Cost FREE, Dinner and refreshments will be provided on site

This dinner workshop will bring attendees an overview of the content showcased at the
2018 International AIDS Conference held in Amsterdam, as well as a number of complex HIV cases to discuss. The first session is a conference report back
session. Professor Mark Boyd will provide an update on the latest studies, important
developments and best research methods in the ongoing battle against HIV, AIDS and
related infectious diseases from the IAS Conference 2018.

The second session will be an interactive panel discussion, focussing on the
management of complex HIV cases. Panellists include Professor Mark Boyd, Dr Russell Waddell (Consultant Sexual Health Physician and Clinical Director STD Services, Royal Adelaide Hospital) and Dr Andrew Beckwith (Senior Consultant Psychiatrist, Director of Training, HIV/Hep C Liaison Psychiatrist, CALHN Mental Health). The session will be hosted by Dr Samuel Elliott (Principal General Practitioner, Riverside Family Medical Practice).

This course is also available as a webinar, please contact Emma Williams here
for webinar registration

Register for this course at:
http://www.ashm.org.au/training/
Registrations close: Friday, 19 October 2018

Download flyer here: HIV Prescriber Update_24Oct2018

Hepatitis C cure leads to improved quality of life

hivandhepatitis.com, 23 October 2017

 People who were cured of hepatitis C with direct-acting antivirals (DAAs) had sustained improvements in their health-related quality of life, including both physical and mental health measures, according to study results presented at the 2017 AASLD Liver Meeting this week in Washington, DC.

Australasian HIV&AIDS + Sexual Health Conferences – registrations closing soon

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, October 2017

Registrations for these conferences are closing soon:

The Australasian HIV&AIDS Conference

The Australasian HIV&AIDS Conference is the premier HIV Conference in Australia and the Asia and Pacific region. The annual conference is run by ASHM as a platform for the dissemination and presentation of new and innovative research findings across the Australasian HIV sector.

Delegates to the conference come from a range of professional backgrounds including basic science, clinical medicine, community programs, education, epidemiology, indigenous health, international and regional issues, nursing and allied health, policy, primary care, public health and prevention, and social research.

Date: 6-8 November 2017

Location: National Convention Centre Canberra

Australasian Sexual Health Conference

The Australasian Sexual Health Alliance seeks to use the Australasian Sexual Health Conference to achieve its purpose of acknowledging and building on the specific expertise of sector partners in the common aims of improving national and local responses to sexual health in Australasia, in supporting and collaborating with close neighbouring countries to achieve these objectives.

Taking forward the agenda for re-thinking sexual health established by the 2016 Australasian Sexual Health Conference in Adelaide, this year’s interdisciplinary conference addresses how sexual health can be re-formed: firstly towards more integrated and personalised provision attuned to people’s needs; and secondly, to make more streamlined and cost-effective use of available resources.

Date: 7-9 November 2017

Location: National Convention Centre Canberra

Download conference flyers

People who use drugs require prioritisation not exclusion in efforts to eliminate Hepatitis C

6th International Symposium on Hepatitis Care in Substance Users,  6th Sept 2017

An international conference bringing together hepatitis C experts from around the world is today calling for strategies to prioritise people who use drugs, saying hepatitis C elimination is impossible without them.

“The number of people around the world dying from hepatitis C is increasing. We have the tools to reverse this trend, to eliminate this disease and save millions of lives. But it will not happen until people who use drugs become a focus of our efforts,” said Associate Professor Jason Grebely, President of the International Network of Hepatitis C in Substance Users (INHSU), the convenors of the conference.

 

Child Living with HIV Maintains Remission Without Drugs Since 2008

National Institute of Allergy and Infectious Diseases (NIAID), July 24, 2017

A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received anti-HIV treatment during infancy has suppressed the virus without anti-HIV drugs for eight and a half years, scientists reported today at the 9th IAS Conference on HIV Science in Paris. This case appears to be the third reported instance of sustained HIV remission in a child after early, limited anti-HIV treatment.

UK report gives thumbs up to generic HIV drugs used as PrEP

A sexual health clinic in London has tested drug levels in users of generic PrEP medication bought online and found the drugs are genuine and effective.

Tests found adequate levels of both emtricitabine and tenofovir (used in PrEP medication Truvada) in patients’ blood, and no sample suggesting counterfeit drugs.